These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20036806)

  • 1. Functional genomics in identification of drug targets in Dupuytren's contracture.
    Sedic M; Jurisic D; Stanec Z; Hock K; Pavelic K; Kraljevic Pavelic S
    Front Biosci (Landmark Ed); 2010 Jan; 15(1):57-64. PubMed ID: 20036806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique microRNA profile in Dupuytren's contracture supports deregulation of β-catenin pathway.
    Mosakhani N; Guled M; Lahti L; Borze I; Forsman M; Pääkkönen V; Ryhänen J; Knuutila S
    Mod Pathol; 2010 Nov; 23(11):1544-52. PubMed ID: 20676061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis to identify novel diagnostic and therapeutic targets for Dupuytren's disease.
    Park TH; Kim D; Lee YS; Kim SY
    Wound Repair Regen; 2020 Mar; 28(2):202-210. PubMed ID: 31688987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using functional genomics to identify drug targets: a Dupuytren's disease example.
    Sedic M; Pavelic SK; Hock K
    Methods Mol Biol; 2012; 910():15-31. PubMed ID: 22821590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The collagen changes of Dupuytren's contracture.
    Murrell GA; Francis MJ; Bromley L
    J Hand Surg Br; 1991 Aug; 16(3):263-6. PubMed ID: 1960490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Collagen metabolism in Dupuytren's contracture].
    Balaba TIa; Furtseva LN; Shinkarenko IN; Abdurazakov UA
    Vopr Med Khim; 1978; 24(6):818-21. PubMed ID: 734986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free radicals and Dupuytren's contracture.
    Murrell GA; Francis MJ; Bromley L
    Br Med J (Clin Res Ed); 1987 Nov; 295(6610):1373-5. PubMed ID: 2825907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dupuytren's disease susceptibility gene, EPDR1, is involved in myofibroblast contractility.
    Staats KA; Wu T; Gan BS; O'Gorman DB; Ophoff RA
    J Dermatol Sci; 2016 Aug; 83(2):131-7. PubMed ID: 27245865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dupuytren's Contracture: A Bibliometric Study of the Most Cited Papers.
    Joyce CW; Joyce KM; Rahmani G; Carroll SM; Kelly JL; Regan PJ
    Hand Surg; 2015 Oct; 20(3):402-9. PubMed ID: 26388001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An insight into Dupuytren's contracture.
    Murrell GA
    Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dupuytren's: a systems biology disease.
    Rehman S; Goodacre R; Day PJ; Bayat A; Westerhoff HV
    Arthritis Res Ther; 2011; 13(5):238. PubMed ID: 21943049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?
    Bianchi E; Taurone S; Bardella L; Signore A; Pompili E; Sessa V; Chiappetta C; Fumagalli L; Di Gioia C; Pastore FS; Scarpa S; Artico M
    Clin Sci (Lond); 2015 Oct; 129(8):711-20. PubMed ID: 26201022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Firebreak' grafts in Dupuytren's contracture.
    Hueston JT
    Aust N Z J Surg; 1984 Jun; 54(3):277-81. PubMed ID: 6380478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enigma that is Dupuytren's contracture.
    Davis TR
    J Hand Surg Eur Vol; 2015 Feb; 40(2):121-3. PubMed ID: 25618866
    [No Abstract]   [Full Text] [Related]  

  • 15. Microarray analysis of Dupuytren's disease cells: the profibrogenic role of the TGF-β inducible p38 MAPK pathway.
    Ratkaj I; Bujak M; Jurišić D; Baus Lončar M; Bendelja K; Pavelić K; Kraljević Pavelić S
    Cell Physiol Biochem; 2012; 30(4):927-42. PubMed ID: 22965824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative genomic and transcriptomic analysis of genetic markers in Dupuytren's disease.
    Jung J; Kim GW; Lee B; Joo JWJ; Jang W
    BMC Med Genomics; 2019 Jul; 12(Suppl 5):98. PubMed ID: 31296227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness in the management of Dupuytren's contracture. A Canadian cost-utility analysis of current and future management strategies.
    Baltzer H; Binhammer PA
    Bone Joint J; 2013 Aug; 95-B(8):1094-100. PubMed ID: 23908426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupuytren's disease: a localised and accessible human fibrotic disorder.
    Layton TB; Williams L; Nanchahal J
    Trends Mol Med; 2023 Mar; 29(3):218-227. PubMed ID: 36566101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors in the pathogenesis of Dupuytren's contracture.
    Al-Qattan MM
    J Hand Surg Am; 2006 Nov; 31(9):1527-34. PubMed ID: 17095386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dupuytren's disease. State of the art and therapeutic perspectives].
    Corrado A; Cantatore FP
    Reumatismo; 2007; 59(2):118-28. PubMed ID: 17603691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.